Log in to save to my catalogue

Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for CO...

Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for CO...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_195f2920a6b9409eb0a1e804fe2e5432

Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for COVID-19: An Italian Registry

About this item

Full title

Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for COVID-19: An Italian Registry

Publisher

Switzerland: MDPI AG

Journal title

Journal of cardiovascular development and disease, 2022-01, Vol.9 (1), p.15

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

It is uncertain whether exposure to renin-angiotensin system (RAS) modifiers affects the severity of the new coronavirus disease 2019 (COVID-19) because most of the available studies are retrospective.
We tested the prognostic value of exposure to RAS modifiers (either angiotensin-converting enzyme inhibitors [ACE-Is] or angiotensin receptor blo...

Alternative Titles

Full title

Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for COVID-19: An Italian Registry

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_195f2920a6b9409eb0a1e804fe2e5432

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_195f2920a6b9409eb0a1e804fe2e5432

Other Identifiers

ISSN

2308-3425

E-ISSN

2308-3425

DOI

10.3390/jcdd9010015

How to access this item